Brief Research Report
Published on 05 Jul 2022
Ruxolitinib as an Effective and Steroid-Sparing First-Line Treatment in Newly Diagnosed BOS Patients After Hematopoietic Stem Cell Transplantation
in Inflammation Pharmacology
- 4,843 views
- 7 citations
Brief Research Report
Published on 05 Jul 2022
in Inflammation Pharmacology
Original Research
Published on 27 Apr 2023
in Primary Immunodeficiencies
Mini Review
Published on 29 Jun 2023
in Cancer Endocrinology
Original Research
Published on 15 Feb 2021
in Inflammation
Original Research
Published on 05 Feb 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Case Report
Published on 11 Oct 2021
in Hematologic Malignancies
Case Report
Published on 12 Feb 2026
in Veterinary Pharmacology and Toxicology
Original Research
Published on 04 Aug 2020
in Infectious Diseases – Surveillance, Prevention and Treatment
Case Report
Published on 01 May 2023
in Hematologic Malignancies
Original Research
Published on 06 Sep 2021
in Inflammation Pharmacology
Brief Research Report
Published on 25 Mar 2022
in Infectious Diseases: Pathogenesis and Therapy
Original Research
Published on 18 Jul 2024
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 30 Jun 2021
in Alloimmunity and Transplantation
Original Research
Published on 19 Aug 2022
in Respiratory Pharmacology
Original Research
Published on 26 Nov 2025
in Inflammation
Original Research
Published on 11 Dec 2023
in Alloimmunity and Transplantation